Members
The WGND is composed of diverse interested stakeholders in TB drug development, including those working in TB drug R&D, regulators, public health workers, funders, community representatives, advocates and policy-makers.
The WGND membership rests with individuals, not institutions. Thus, the WGND has no "lead agency" and is not dominated by any institution or group of institutions. Members represent the private and public sectors and come from diverse geographical locations.
Apply Now Learn More View Core GroupCurrent Members
| Name | Organization |
Country
|
|---|---|---|
| Hugo Cesar Gramajo | Instituto de Biologia Molecular y Celular de Rosario | Argentina |
| Ahmadul Khan | Ahmadul Hasan Khan | Bangladesh |
| Anil Koul | Johnson and Johnson | Belgium |
| Koen Andries | Janssen | Belgium |
| Fernando Pavan | Sao Paulo State University, UNESP, Brazil | Brazil |
| Marcio Dias | University of Sao Paulo | Brazil |
| Valerie Flore Donkeng Donfack | Pasteur Center in Cameroon | Cameroon |
| Yossef Av-Gay | University of British Columbia | Canada |
| Renaud Boulanger | McGill University | Canada |
| Doug Lowrie | Fudan University's Shanghai Public Health Clinical Center | China |
| Xuelian Zhang | Fudan University | China |
| Martin Dolezal | Charles University in Prague, Faculty of Pharmacy in Hradec Kralove | Czech Republic |
| Teto Fondacaro Mamona | Programme National de Lutte Contre la Tuberculose | Democratic Republic Of Congo (Zaire) |
| Tarek Aboul-Fadl | Medicinal Chemistry, Assiut University | Egypt |
| Yadav Prasad Joshi | Biodyss and Journal Infection in Developing Countries | France |
| Nicolas Willand | Institut Pasteur Lille | France |
| Brigitte Demers | Sanofi | France |
| Didier Leboulleux | Sanofi | France |
| Florence Bordon-Pallier | Sanofi | France |
| Jacques Grosset | Scientist | France |
| Alexandra Carreau | Sanofi-Adventis R&D | France |
| Isabelle Cieren-Puiseux | Sanofi | France |
| Nelly Solomonia | National Center for Tuberculosis and Lung Diseases | Georgia |
| Nino Lomtadze | National Center for Tuberculosis and Lung Diseases | Georgia |
| Tamari Trapaidze | Welfare Foundation | Georgia |
| Norbert Heinrich | Universtiy of Munich / PanACEA | Germany |
| Michael Hoelscher | Ludwig-Maximilians-University | Germany |
| Nii Nortey Hanson-Nortey | Ghana Health Service | Ghana |
| Kobina Bosumtwi Dadzie | Wiljok Childaid and Health Organization | Ghana |
| Sandeep Saluja | No affiliation | India |
| Prasad Pasam | Shar Technologies Group | India |
| Rajender Kamboj | Lupin Limited | India |
| Tanjore Balganesh | CSIR-OSDD | India |
| Avishek Anant | Novartis | India |
| P. R. Narayanan | Tuberculosis Research Centre, Chennai (retired) | India |
| Kanury Rao | International Centre for Genetic Engineering & Biotechnology-New Delhi | India |
| Samir Roy | Government Medical College, Bhavnagar | India |
| Dhanji Rajani | Microcare Laboratory | India |
| Shekhar Mande | National Centre for Cell Science | India |
| Ravishankar Ramachandran | CSIR-Central Drug Research Institute, Lucknow, India | India |
| Shreemanta Parida | Clinical Scientist | India |
| Kampasati Satyanarayana | Yuvabharath Society | India |
| Sidharth Chopra | Central Drug Research Institute, Lucknow | India |
| Khadar Bhatcha | PSG College of Pharmacy | India |
| KR John | SRM Medical College | India |
| Ronan O'Toole | Trinity College Dublin | Ireland |
| Oren Zimhony | Kaplan Medical Center, The School of Medicine Hebrew University | Israel |
| Dario Scaramuzzi | R-Evolution Group EEIG | Italy |
| Daniela Jabes | NeED Parma | Italy |
| Masaji Okada | Clinical Research Center, National Hospital Organization Kinki-Chuo Chest Medical Center | Japan |
| Tado Shimao | Japan Anti-Tuberculosis Association (JATA) Research Institute of TB | Japan |
| Hiromu Kawakubo | Asahi Kasei Chemicals Corporation | Japan |
| Noroi Doi | Japan Anti-Tuberculosis Association (JATA) Research Institute of TB | Japan |
| Steve Wandiga | KEMRI/CDC | Kenya |
| Dorothy Odhiambo | International Community of Women Living with HIV in Kenya ( ICW-K) | Kenya |
| Benson Muriuki | Center for the Empowerment Of The Local Herbalist-Celoh Kenya | Kenya |
| Nelson Otwoma | Positive Familes Network (+FN) | Kenya |
| Alick Chimpimo Makiyi | Grassroots Movement for Health and Development (GMHD) | Malawi |
| Rogelio Hernandez Pando | National Institute of Medical Sciences and Nutrition, Mexico | Mexico |
| Htay Lwin | National TB Program, Myanmar | Myanmar (Burma) |
| Astrid Van der Sar | VU University Medical Center | Netherlands |
| Daniel Zollinger | QareFree | Netherlands |
| Martin Johan Boeree | PanACEA Consortium and the Radboud University Nijmegen Medical Centre | Netherlands |
| Jurriaan de Steenwinkel | Erasmus MC | Netherlands |
| Kolawole Ekanoye | Advocates for Health and Development Initiative | Nigeria |
| Muhammad Farooq | Government of Pakistan | Pakistan |
| Basharat Khan | National TB Control Programme | Pakistan |
| Zahoor Ahmed | National TB Control Programme | Pakistan |
| Mohammad Hassan Mashori | Fundamental Human Rights & Rural Development Association (FHRRDA) | Pakistan |
| Asghar Arif | TB Association Charsadda Pak | Pakistan |
| Roberto Salvino | No affiliation | Philippines |
| Sergey Koren | JSC Pharmasyntez | Russia |
| Aboubacar Sidiki Daffe | Université Cheikh Anta DIOP | Senegal |
| Christian Lienhardt | World Health Organization (WHO) | Senegal |
| Manjunatha Ujjini | Novartis Institute for Tropical Diseases | Singapore |
| Josef Jampilek | Comenius University | Slovakia |
| Abdifetah Ibrahim Omer | National TB Programme Somalia | Somalia |
| Parameshwar Makam | University of KwaZulu-Natal | South Africa |
| Kristina Wallengren | THINK | South Africa |
| Hulda Swai | Council of Scientific Industrial Research (CSIR) in South Africa | South Africa |
| Bavesh Kana | University of the Witwatersrand/National Health Laboratory Service | South Africa |
| Anneke Hesseling | Desmond Tutu TB Centre | South Africa |
| Bernard Fourie | University of Pretoria | South Africa |
| Gerhard Walzl | Stellenbosch University | South Africa |
| Wim Vandevelde | European AIDS Treatment Group (EATG); Community Representative | South Africa |
| Victoria Kasprowicz | SANTHE | South Africa |
| Regina Osih | Clinton Health Access Initiative | South Africa |
| Andreas Diacon | University of Stellenbosch | South Africa |
| Valerie Mizrahi | UCT-Institute of Infectious Disease and Molecular Medicine | South Africa |
| Gill Black | Sustainable Livelihoods Foundation | South Africa |
| Dalene von Delft | TB Proof | South Africa |
| Chris Edlin | iThemba Pharmaceuticals | South Africa |
| Boitumelo Semete | Council of Scientific Industrial Research (CSIR) in South Africa | South Africa |
| Christo van Niekerk | TB Alliance | South Africa |
| Jonathan Blackburn | University of Cape Town | South Africa |
| Robert Wallis | Aurum Institute | South Africa |
| Sang Nae Cho | Yonsei University College of Medicine | South Korea |
| Sang Jae Kim | Korean Institute of Tuberculosis | South Korea |
| Kevin Pethe | Institut Pasteur-Korea | South Korea |
| Lluís Ballell | GlaxoSmithKline Tres Cantos | Spain |
| David Barros | GlaxoSithKline | Spain |
| Santiago Ramón García | Research Agency of Aragon (ARAID) | Spain |
| Joan A. Cayla | Agència de Salut Pública de Barcelona | Spain |
| Pere-Joan Cardona | Institut Germans Trias i Pujol (IGTP) | Spain |
| Robert Bates | GlaxoSmithKline | Spain |
| Asaad Khalid Ahmed | National Center for Research | Sudan |
| Stephen Matlin | Global Forum for Health Research | Switzerland |
| Mario Raviglione | Università degli Studi di Milano | Switzerland |
| Rick O'Brien | Switzerland | |
| Marc Gitzinger | BioVersys AG | Switzerland |
| Malgosia Grzemska | World Health Organization (WHO) | Switzerland |
| Stewart Cole | Institut Pasteur | Switzerland |
| Iain Old | Innovative Medicines for TB (iM4TB) | Switzerland |
| Neeraj Dhar | École Polytechnique Fédérale de Lausanne (EPFL) | Switzerland |
| Klaus Reither | Swiss Tropical and Public Health Institute | Tanzania |
| Prasit Palittapongarnpim | Mahidol University | Thailand |
| Sonja Henne | MSF | Tunisia |
| Yap Boum II | Epicentre/MSF | Uganda |
| Joshua Wamboga | Uganda Network of AIDS Service Organisations (UNASO) | Uganda |
| Galyna Kutsyna | Luhansk State Medical University | Ukraine |
| Andriy Dudnyk | National Medical University of Vinnytsia, Ukraine | Ukraine |
| Sanjib Bhakta | The Institute of Structural and Molecular Biology, Birkbeck, University of London | United Kingdom |
| Oscar Della Pasqua | GlaxoSmithKline | United Kingdom |
| Simon Tiberi | Barts Healthcare NHS Trust | United Kingdom |
| Arun Kumar Mishra | University of Birmingham | United Kingdom |
| Polly Clayden | HIV i-Base | United Kingdom |
| Amina Jindani | St. George's, University of London | United Kingdom |
| Juan David Guzman | Birkbeck College | United Kingdom |
| Brian Robertson | Imperial College London | United Kingdom |
| Roger Moses | iThemba Pharmaceuticals | United Kingdom |
| Ibrahim Abubakar | University College London, MRC Clinical Trials Unit | United Kingdom |
| Richard White | London School of Hygiene and Tropical Medicine | United Kingdom |
| Tiansheng Wang | Vertex Pharmaceuticals | United States |
| Chris Dippel | Peloton Partnering, SP | United States |
| Cherise Scott | TB Alliance | United States |
| Khisimuzi Mdluli | Bill and Melinda Gates Medical Research Institute | United States |
| Clifton Barry | National Institute for Allergy and Infectious Diseases (NIH/NIAID) | United States |
| Ying Zhang | Johns Hopkins University | United States |
| Erica Lessem | Treatment Action Group | United States |
| Bolin Geng | Ra Pharma | United States |
| Anne Lenaerts | Colorado State University | United States |
| Charles Wells | Sanofi | United States |
| David McNeeley | Medical Service Corportation International (MSCI) | United States |
| Gail Cassell | Infectious Disease Research Institute (IDRI) | United States |
| James Frincke | Hollis Eden Pharmaceuticals | United States |
| Leo Einck | Sequella, Inc. | United States |
| Tawanda Gumbo | Baylor University | United States |
| Omar Vandal | Bill and Melinda Gates Foundation | United States |
| Christopher Cooper | Global Alliance for TB Drug Development (TB Alliance) | United States |
| Matthew Price | Harvard School of Public Health | United States |
| Michaela Nielsen | Regulatory Affairs Consultant | United States |
| C. Robert Horsburgh | Boston University School of Public Health | United States |
| Edward Berry | SUNY Upstate Medical University | United States |
| Peter Warner | Bill and Melinda Gates Foundation | United States |
| Andrew Vernon | U.S. Centers for Disease Control and Prevention (CDC) | United States |
| Carol Dukes Hamilton | Family Health International | United States |
| Christopher Locher | Baxalta | United States |
| Kenneth Castro | Emory University | United States |
| Ute Muh | University of Iowa | United States |
| Maggie McCammon | Michigan Economic Development Corporation | United States |
| Bob Goldman | RCG Consulting | United States |
| Martin Graham | KinderPharm | United States |
| Shashank Gupta | Brown University | United States |
| Laura Via | National Institute for Allergy and Infectious Diseases (NIH/NIAID) | United States |
| Christine Sizemore | Fogarty International Center at NIH | United States |
| Jan Gheuens | Bill & Melinda Gates Foundation | United States |
| Mamodikoe Makhene | National Institute for Allergy and Infectious Diseases (NIH/NIAID) | United States |
| Michael Cynamon | VAMC, SUNY, Upstate Medical University | United States |
| Thomas Dick | University in New Jersey UMDNJ-New Jersey Medical School | United States |
| Jing Bao | Frontier Biotechnologies, LLC | United States |
| Joel Freundlich | UMDNJ - New Jersey Medical School | United States |
| Frances Pappas | TB Alliance | United States |
| Oleg Tsodikov | University of Kentucky | United States |
| Anthony Baughn | University of Minnesota | United States |
| Mary Jackson | Colorado State University | United States |
| Payam Nahid | University of California, San Francisco | United States |
| Carl Nathan | Weill Cornell Medical College | United States |
| Shichun Lun | Johns Hopkins University School of Medicine | United States |
| Jim Boyce | National Institute for Allergy and Infectious Diseases (NIH/NIAID) | United States |
| Anna Upton | TB Alliance | United States |
| Carole Mitnick | Harvard Medical School | United States |
| David Sherman | University of Washington | United States |
| Lawrence Geiter | Otsuka Pharmaceutical Company | United States |
| Mary Ann de Groote | Colorado State University | United States |
| Robert Husson | Children's Hospital Boston/Harvard Medical School | United States |
| Barry Bunin | Collaborative Drug Discovery | United States |
| Sylvie Garneau-Tsodikova | University of Michigan | United States |
| Gilla Kaplan | United States | |
| Bonita Mangura | Global TB Institute at UMDNJ | United States |
| Christopher Sassetti | University of Massachusetts Medical School | United States |
| Doris Rouse | RTI International | United States |
| Ken Duncan | Bill & Melinda Gates Foundation | United States |
| Marina Protopopova | National Institute for Allergy and Infectious Diseases (NIH/NIAID) | United States |
| Todd Waldman | Easton Associates | United States |
| Gail Tauscher | National Institute for Allergy and Infectious Diseases (NIH/NIAID) | United States |
| Heinz Moser | Achaogen | United States |
| Helena Boshoff | National Institutes of Health (NIH) | United States |
| Kyu Rhee | Weill Cornell Medical College | United States |
| Petros Karakousis | Johns Hopkins University School of Medicine | United States |
| Rajneesh Taneja | TB Alliance | United States |
| John Szumowski | Santa Clara Valley Medical Center | United States |
| Cathy Bansbach | Bill & Melinda Gates Foundation | United States |
| Allen Casey | Infectious Disease Research Institute (IDRI) | United States |
| Barbara Laughon | National Institute for Allergy and Infectious Diseases (NIH/NIAID) | United States |
| Diane Ordway | Colorado State University | United States |
| Gary Horwith | BARDA | United States |
| James Love | Knowledge Ecology International (KEI) | United States |
| Melvin Spigelman | TB Alliance | United States |
| Richard Chaisson | Johns Hopkins University Center for TB Research | United States |
| Tanya Parish | Infectious Disease Research Institute (IDRI) | United States |
| Philip Hipskind | Lgenia | United States |
| Sharon Williams | National Institute for Allergy and Infectious Diseases (NIH/NIAID) | United States |
| Mark Harrington | Treatment Action Group | United States |
| Debra Hanna | Bill and Melinda Gates Foundation | United States |
| Brian VanderVen | Cornell University | United States |
| Ann Ginsberg | IAVI | United States |
| Carol Nacy | Sequella, Inc. | United States |
| Claire Wingfield | PATH | United States |
| Eric Nuermberger | Johns Hopkins University | United States |
| Martin Springsklee | Bayer Healthcare | United States |
| Scott Franzblau | Institute for Tuberculosis Research, University of Illinois at Chicago | United States |
| William Bishai | Johns Hopkins School of Medicine | United States |
| William Chamberlin | Texas Tech University Health Sciences Center | United States |
| Jerome Zeldis | Celgene | United States |
| Edward Nardell | Partners in Health | United States |
| David Russell | Cornell University | United States |
| Jeffery Cirillo | Texas A&M Health Science Center | United States |
| Shashi Kant | UT Southwestern Medical Center | United States |
| Liyanage Perera | National Institutes of Health (NIH) | United States |
| Francisco Leyva | National Institute for Allergy and Infectious Diseases (NIH/NIAID) | United States |
| Amy Bloom | United States Agency for International Development (USAID) | United States |
| Dirk Schnappinger | Weill Cornell Medical College | United States |
| Gyanu Lamichhane | Johns Hopkins University | United States |
| Maria Freire | Foundation for NIH | United States |
| Takushi Kaneko | TB Alliance | United States |
| Gustavo E. Velásquez | University of California, San Francisco | USA |
| Albert Makone | Community Representative; Global Fund (local) | Zimbabwe |
| Philip Onyebujoh | WHO Regional Office for Africa | Zimbabwe |
New Members
The Working Group pipeline is open to anyone who is developing a TB drug. If you would like to become a member, please submit an application.
Apply NowQuestions? Contact Us